Hosted by Dailymotion. For legal issues report at the Copyright Center, report us on DMC, or use the Instant Removal tool.
Shire goes Viro
2 Views • Mar 04, 2019
Description
Shire is bolstering its rare diseases drug portfolio with a $4.2bn acquisition of ViroPharma. Lex's Nikki Tait and Vincent Boland discuss how this big buy fits with the pharmaceuticals company's cost drive.
For more video content from the Financial Times, visit http://www.FT.com/video
Subscribe to the Financial Times on YouTube; http://goo.gl/vUQx5k
Twitter https://twitter.com/ftvideo
Facebook https://www.facebook.com/financialtimes
Keywords & Tags
More from User
EU leaders offer the UK a six-month Brexit delay
Financial Times
ECB keeps monetary policy unchanged
Financial Times
Theresa May granted Brexit delay until end of October
Financial Times
Crunched: philanthropy versus tax avoidance
Financial Times
How scientists took first picture of a black hole
Financial Times
Theresa May arrives in Brussels seeking Brexit delay
Financial Times
Related Videos
ET NOW, india, finance, economy, business, news, finance minister, politics, times of india,timesgroup, times, et, et now, corporate,discussion
ET NOW
[PDF] The Basics of Finance: An Introduction to Financial Markets, Business Finance, and Portfolio
Zonaboutwell
CNNMoney - Business, financial and personal finance news
ammar yasir
Small Business financing scams and commercial loans...financial training academy
Webcam
Critical Finance Tips for Small Businesses During COVID-19 | Lower Your Financial Risk in This Pandemic
Nathan A Berneman
Read Handbook of Corporate Finance: A Business Companion to Financial Markets Decisions and
Hasselmann